JP Morgan Chase’s CARGO Therapeutics CRGX Stock Holding History

JP Morgan Chase’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-208,792	Closed	-$860K	–	7442
2025 Q2	$860K	Buy	208,792 +189,282	+970%	+$811K	﹤0.01%	4473
2025 Q1	$79.4K	Buy	19,510 +444	+2%	+$2.97K	﹤0.01%	5679
2024 Q4	$275K	Buy	19,066 +4,059	+27%	+$73.7K	﹤0.01%	5337
2024 Q3	$277K	Buy	15,007 +6,426	+75%	+$115K	﹤0.01%	5248
2024 Q2	$141K	Buy	8,581 +143	+2%	+$2.72K	﹤0.01%	5348
2024 Q1	$188K	Buy	+8,438	New	+$201K	﹤0.01%	5387

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JP Morgan Chase's CRGX Position: Q3 2025 in Review

JP Morgan Chase sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 208,792 shares — an estimated $860K sold.

JP Morgan Chase first reported a position in CRGX in Q1 2024 and held it in 6 quarters. The position peaked at $860K in Q2 2025. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

JP Morgan Chase reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
JP Morgan Chase sold 208,792 CARGO Therapeutics shares in Q3 2025, an estimated $860K.
JP Morgan Chase first reported a position in CARGO Therapeutics in Q1 2024 and held it in 6 quarters.
JP Morgan Chase's CARGO Therapeutics position peaked at $860K in Q2 2025.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on JP Morgan Chase's 13F filing for Q3 2025, filed 7 Nov 2025.